NeuroBo Pharma (NRBO) - Market Capitalization

NeuroBo Pharmaceuticals (NRBO) is fighting for market share in the metabolic disorders segment, challenging the influence of industry behemoths. The company is automating bioanalysis using AI and robotics to accelerate drug discovery. The price indicator on the chart recorded a value of 0.02. Risks are being minimized through the development of treatments for obesity and liver pathologies, ensuring the business's financial stability.

NRBO NeuroBo Pharmaceuticals, Inc.: Market Value in the range 07/04/2022 - 12/07/2024

NRBO (NeuroBo Pharmaceuticals, Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart NeuroBo|NRBO - Fair Value Consensus

- market capitalization indicators:

Market Capitalization NeuroBo Pharmaceuticals, Inc.|NRBO - Total Company Value

- issuer book value statistics:

Net Assets per Single Share NeuroBo Pharmaceuticals|NRBO - Total Stockholders' Equity|Market Value to Book Value Ratio neurobopharma.com|NRBO - Total Business Assets

- business debt structure and liquidity details:

Total Debt to Capital NeuroBo Pharmaceuticals|NRBO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio neurobopharma.com|NRBO - Company Aggregate Debts|Debt to Book Capitalization Ratio NeuroBo Pharmaceuticals Inc|NRBO - Company Long-Term Loans and Borrowings|Company Short-Term Debt NeuroBo Pharmaceuticals|Quick Liquidity neurobopharma.com

- business earnings and investment ratios data:

NRBO - Company Profit|Projected Future Earnings NeuroBo Pharmaceuticals|NRBO - Market Cap to Earnings|Projected Price to Earnings NeuroBo Pharma|NRBO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroBo Pharmaceuticals Inc|NRBO - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months NeuroBo Pharmaceuticals|NRBO - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth neurobopharma.com|NRBO - Earnings per share growth in current year|Net earnings per share growth forecast for next year NeuroBo Pharmaceuticals

- revenue and sales details:

NRBO - Company Total Revenue|Company Future Sales Volume NeuroBo|NRBO - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio NeuroBo Pharmaceuticals|NRBO - Trailing Twelve Months Sales Growth

Fundamental company analysis:NRBO (NeuroBo)

NeuroBo Pharmaceuticals (NRBO) developments in neuroscience are critically dependent on FDA approval and the influx of R&D capital. An analysis of the issuer's market capitalization allows for the real-time tracking of the total market value of all shares. This metric aggregates the current quote and the total number of securities, reflecting the collective valuation of the business. This chart helps promptly assess investment attractiveness and drawdown risks. The shares are classified as high-risk biotechnological assets.

Key competitors